Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Telesis Bio Inc's Business Segments

Telesis Bio Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY

Reportable Segments

Per the company's own filing, this quarter

Largest Segment

Total Revenue

$ 2

Consolidated, this quarter

Regions Reported

Geographic regions, this quarter

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/TBIO/segments                    

                        https://api.csimarket.com/api/v1/companies/TBIO/geographic                    

                        https://api.csimarket.com/api/v1/companies/TBIO/exposure                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Telesis Bio Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.

Revenue by Product & Service Category - FY

Product59.4%
Royalties and Other Revenue40.6%
License0%

Revenue by Product & Service Category - FY

Category	Period	Revenue (Millions)	% of Total
Product	FY	$ 1	59.4%
Royalties and Other Revenue	FY	$ 1	40.6%
License	FY	-	0%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

Description of Telesis Bio Inc

Telesis Bio Inc is a biotechnology company specializing in the development and manufacturing of products derived from natural sources for agriculture, animal health, and human health industries. The company develops biopesticides and biofertilizers designed to be safe, effective, and environmentally friendly, aiming to replace chemical pesticides and fertilizers. Their biopesticides target specific pests while preserving beneficial organisms, and their biofertilizers utilize natural microorganisms to enhance nutrient availability and plant growth. In animal health, Telesis Bio produces probiotics and feed supplements that support gut health, improve digestion, nutrient absorption, and disease resistance. The company also engages in research and development of novel therapeutics in immunology and infectious diseases, focusing on combating antibiotic resistance and developing alternative treatments. Telesis Bio operates manufacturing facilities that employ advanced biotechnology processes with stringent quality control to ensure product consistency and purity. Their manufacturing emphasizes environmental sustainability by minimizing waste and energy consumption. The company collaborates with academic institutions, research organizations, and industry partners to support its research initiatives and participates in scientific conferences and symposiums. Telesis Bio is committed to sustainable business practices, including reducing its carbon footprint, implementing energy-efficient technologies, recycling, ethical sourcing, and supply chain transparency. Additionally, the company supports philanthropic activities related to education, healthcare, and environmental conservation.

The Company operates multiple business activities managed by individual segment managers; however, the chief operating decision maker (CODM), who is the chief executive officer, reviews operating results solely on a consolidated basis. As a result, the Company has one operating segment and one reportable segment.